Columbia University

Technology Ventures

TRx and CTV Translational Therapeutics Seminar: RBP4 Antagonists for Treatment of Macular Degeneration- Small Molecule Drug Discovery in an Academic Setting

June 19, 2017
Konstantin Petrukhin, PhD
Irving Institute (PH10-405)
622 W. 168th Street, 10th floor
New York, NY

The TRx pilot award is designed to provide education, mentorship, and funding to accelerate early-stage therapy discovery towards the clinic. The Translational Therapeutics Seminar Series is a 6-part series which will include speakers with varying perspectives on the drug development process, ranging from an academic investigator’s experiences to an industry investor’s perspective. 

Part six of the series features Dr. Konstantin Petrukhin, Associate Professor, Department of Opthamology at Columbia University Medical Center. 

For more information, please contact Maria Rahmany at